Kusnandi Rusmil, Chief, Covid-19 Vaccine Research & Clinical Trial Team: We Got a Head Start to Develop the Vaccine Faster - Interview - magz.tempo.co

maaf email atau password anda salah

Kusnandi Rusmil, Chief, Covid-19 Vaccine Research & Clinical Trial Team: We Got a Head Start to Develop the Vaccine Faster

Monday, August 3, 2020

The phase III clinical trial of Sinovac Biotech Ltd’s Covid-19 vaccine has generated a lot of interest from prospective volunteers. Four days after the open registration began, over 1,000 volunteers have signed up for the trial conducted by the research team from the faculty of medicine of the Padjadjaran University in Bandung, West Java.

Kusnandi Rusmil, Chief, Covid-19 Vaccine Research & Clinical Trial Team/TEMPO/Prima Mulia. tempo : 173486483175.

THE research team needed 1,620 volunteers from among Bandung residents for the trial. Besides being required to be healthy and free of Covid-19, potential candidates must be 18 to 59 years old. “I’m looking for the age group with a relatively strong immune system,” Kusnandi Rusmil, 70, the team leader, said during a special interview with Tempo via video conference on Tuesday, July 28.

The trial offers new hope as the case

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

*You Save -Rp 102.000
*Guaranteed update of up to 52 Editions of Tempo Magazine

Subscribe

Rp 64.380/Month

Active Every Month Cancel Anytime

*Free for the first month if using a Credit Card

Subscribe

See Other Packages

Already a Subscribed?
To receive daily news by Email,

More Articles

Tempo English Monday, August 3, 2020
Tempo English Monday, August 3, 2020
Tempo English Monday, August 3, 2020
Tempo English Monday, August 3, 2020

More exclusive contents

December 16, 2024
December 9, 2024
December 2, 2024
November 25, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.